Lv51
900 积分 2023-02-01 加入
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2小时前
待确认
Unlocking the Potential: Biomarkers of Response to Antibody-Drug Conjugates
2小时前
已完结
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer
2小时前
已完结
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2小时前
已完结
Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding
3小时前
已完结
[18F]RCCB6 PET/CT in Diagnosing Clear Cell Renal Cell Carcinomas: A Prospective Comparison Study with [18F]FDG PET/CT and Conventional Imaging
1个月前
已完结
Construction of [89Zr]Zr-Labeled Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles for Noninvasive Detection of Tumors
2个月前
已完结
A Facile Method for the Preparation of S-(Alkylsulfenyl)cysteines
2个月前
已完结
Deep-learning-based HER2 status assessment from multimodal breast cancer data predicts neoadjuvant therapy response
6个月前
已完结
A Comprehensive Analysis of HER2 status Heterogeneity Using Matched Samples among Potential Beneficiaries of Trastuzumab Deruxtecan Therapy in Non-Small Cell Lung Cancer
6个月前
已完结
皖公网安备34019202002308
